Cambridge Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,406
| Closed | -$206K | – | 169 |
|
|
2023
Q3 | $206K | Sell |
1,406
-1,469
| -51% | -$215K | 0.06% | 160 |
|
|
2023
Q2 | $440K | Buy |
2,875
+40
| +1% | +$6.13K | 0.11% | 113 |
|
|
2023
Q1 | $440K | Sell |
2,835
-16
| -0.6% | -$2.48K | 0.11% | 122 |
|
|
2022
Q4 | $439K | Sell |
2,851
-11
| -0.4% | -$1.7K | 0.12% | 119 |
|
|
2022
Q3 | $378K | Sell |
2,862
-554
| -16% | -$73.2K | 0.11% | 122 |
|
|
2022
Q2 | $463K | Buy |
3,416
+16
| +0.5% | +$2.17K | 0.13% | 115 |
|
|
2022
Q1 | $507K | Sell |
3,400
-6
| -0.2% | -$895 | 0.12% | 119 |
|
|
2021
Q4 | $552K | Sell |
3,406
-82
| -2% | -$13.3K | 0.12% | 117 |
|
|
2021
Q3 | $579K | Sell |
3,488
-449
| -11% | -$74.5K | 0.14% | 105 |
|
|
2021
Q2 | $680K | Sell |
3,937
-672
| -15% | -$116K | 0.16% | 91 |
|
|
2021
Q1 | $740K | Buy |
4,609
+480
| +12% | +$77.1K | 0.19% | 85 |
|
|
2020
Q4 | $694K | Buy |
4,129
+457
| +12% | +$76.8K | 0.19% | 82 |
|
|
2020
Q3 | $577K | Buy |
3,672
+2,065
| +129% | +$324K | 0.17% | 89 |
|
|
2020
Q2 | $270K | Buy |
+1,607
| New | +$270K | 0.08% | 126 |
|